Encompass Wealth Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Encompass Wealth Advisors's AMGN Position: Q3 2026 in Review
Encompass Wealth Advisors increased its Amgen (AMGN) stake by 100% in Q3 2026, buying an estimated $1.17M and bringing the position to 5,874 shares worth $2.48M. The position accounts for 0.37% of the portfolio, ranked #40.
Encompass Wealth Advisors first reported a position in AMGN in Q4 2020 and has held it in 24 quarters since. The position peaked at $2.61M in Q1 2021. 2,617 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- Encompass Wealth Advisors held 5,874 shares of Amgen worth $2.48M as of Q3 2026.
- Encompass Wealth Advisors bought 2,937 Amgen shares in Q3 2026, an estimated $1.17M.
- Amgen made up 0.37% of Encompass Wealth Advisors's portfolio in Q3 2026, its #40 holding.
- Encompass Wealth Advisors first reported a position in Amgen in Q4 2020 and has held it in 24 quarters since.
- Encompass Wealth Advisors's Amgen position peaked at $2.61M in Q1 2021.
- 2,617 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on Encompass Wealth Advisors's 13F filing for Q3 2026, filed 15 Oct 2026.